The role of angiomotin phosphorylation in the Hippo pathway during preimplantation mouse development

Tissue Barriers

Volumn 2, Issue 2, 2014, Pages

  Hirate, Yoshikazu ^a   Sasaki, Hiroshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Amot; Amotl2; Blastocyst; F actin; Lats; Merlin Nf2; Taz; Tead4; Yap

Indexed keywords

ACTIN BINDING PROTEIN; ALPHA CATENIN; ANGIOMOTIN; CELL ADHESION MOLECULE; F ACTIN; PEPTIDES AND PROTEINS; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; YAP PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL DISRUPTION; CELL POLARITY; GENE REPRESSION; GENE TARGETING; HIPPO SIGNALING PATHWAY; HUMAN; INNER CELL MASS; NONHUMAN; PREIMPLANTATION EMBRYO; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84907805241     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/tisb.28127     Document Type: Article

References (50)

1. Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev 2013; 27:355-71; PMID:23431053; http://dx.doi.org/10.1101/gad.210773.112
2. Sasaki H. Mechanisms of trophectoderm fate specification in preimplantation mouse development. Dev Growth Differ 2010; 52:263-73; PMID:20100249; http://dx.doi.org/10.1111/j.1440-169X.2009.01158.x
3. Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer 2013; 13:246-57; PMID:23467301; http://dx.doi.org/10.1038/nrc3458
4. Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell 2006; 124:267-73; PMID:16439203; http://dx.doi.org/10.1016/j.cell.2006.01.005
5. Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003; 11:11-23; PMID:12535517; http://dx.doi.org/10.1016/S1097-2765(02)00776-1
6. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007; 130:1120-33; PMID:17889654; http://dx.doi.org/10.1016/j.cell.2007.07.019
7. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007; 21:2747-61; PMID:17974916; http://dx.doi.org/10.1101/gad.1602907
8. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010; 24:72-85; PMID:20048001; http://dx.doi.org/10.1101/gad.1843810
9. Hirate Y, Hirahara S, Inoue K, Suzuki A, Alarcon VB, Akimoto K, Hirai T, Hara T, Adachi M, Chida K, et al. Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr Biol 2013; 23:1181-94; PMID:23791731; http://dx.doi.org/10.1016/j.cub.2013.05.014
10. Nishioka N, Inoue K, Adachi K, Kiyonari H, Ota M, Ralston A, Yabuta N, Hirahara S, Stephenson RO, Ogonuki N, et al. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev Cell 2009; 16:398-410; PMID:19289085; http://dx.doi.org/10.1016/j.devcel.2009.02.003
11. Nishioka N, Yamamoto S, Kiyonari H, Sato H, Sawada A, Ota M, Nakao K, Sasaki H. Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. Mech Dev 2008; 125:270-83; PMID:18083014; http://dx.doi.org/10.1016/j.mod.2007.11.002
12. Yagi R, Kohn MJ, Karavanova I, Kaneko KJ, Vullhorst D, DePamphilis ML, Buonanno A. Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development. Development 2007; 134:3827-36; PMID:17913785; http://dx.doi.org/10.1242/dev.010223
13. Ralston A, Cox BJ, Nishioka N, Sasaki H, Chea E, Rugg-Gunn P, Guo G, Robson P, Draper JS, Rossant J. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development 2010; 137:395-403; PMID:20081188; http://dx.doi.org/10.1242/dev.038828
14. Home P, Saha B, Ray S, Dutta D, Gunewardena S, Yoo B, Pal A, Vivian JL, Larson M, Petroff M, et al. Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitment. Proc Natl Acad Sci U S A 2012; 109:7362-7; PMID:22529382; http://dx.doi.org/10.1073/pnas.1201595109
15. Hirate Y, Cockburn K, Rossant J, Sasaki H. Tead4 is constitutively nuclear, while nuclear vs. cytoplasmic Yap distribution is regulated in preimplantation mouse embryos. Proc Natl Acad Sci U S A 2012; 109:E3389-90, author reply E3391-2; PMID:23169672; http://dx.doi.org/10.1073/pnas.1211810109
16. Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, Rossant J. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005; 123:917-29; PMID:16325584; http://dx.doi.org/10.1016/j.cell.2005.08.040
17. Leung CY, Zernicka-Goetz M. Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms. Nat Commun 2013; 4:2251; PMID:23903990; http://dx.doi.org/10.1038/ncomms3251
18. Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG, Holmgren L. Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 2002; 298:69-77; PMID:12406577; http://dx.doi.org/10.1016/S0378-1119(02)00928-9
19. Wells CD, Fawcett JP, Traweger A, Yamanaka Y, Goudreault M, Elder K, Kulkarni S, Gish G, Virag C, Lim C, et al. A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 2006; 125:535-48; PMID:16678097; http://dx.doi.org/10.1016/j.cell.2006.02.045
20. Sugihara-Mizuno Y, Adachi M, Kobayashi Y, Hamazaki Y, Nishimura M, Imai T, Furuse M, Tsukita S. Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties. Genes Cells 2007; 12:473-86; PMID:17397395; http://dx.doi.org/10.1111/j.1365-2443.2007.01066.x
21. Yi C, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, Christian N, Persson NL, Shimono A, Speicher DW, Marmorstein R, et al. A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 2011; 19:527-40; PMID:21481793; http://dx.doi.org/10.1016/j.ccr.2011.02.017
22. Paramasivam M, Sarkeshik A, Yates JR 3rd, Fernandes MJ, McCollum D. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 2011; 22:3725-33; PMID:21832154; http://dx.doi.org/10.1091/mbc.E11-04-0300
23. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q, Guan KL. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25:51-63; PMID:21205866; http://dx.doi.org/10.1101/gad.2000111
24. Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 2011; 286:4364-70; PMID:21187284; http://dx.doi.org/10.1074/jbc.C110.205401
25. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 2011; 286:7018-26; PMID:21224387; http://dx.doi.org/10.1074/jbc.C110.212621
26. Ernkvist M, Aase K, Ukomadu C, Wohlschlegel J, Blackman R, Veitonmäki N, Bratt A, Dutta A, Holmgren L. p130-angiomotin associates to actin and controls endothelial cell shape. FEBS J 2006; 273:2000-11; PMID:16640563; http://dx.doi.org/10.1111/j.1742-4658.2006.05216.x
27. Shimono A, Behringer RR. Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Curr Biol 2003; 13:613-7; PMID:12676095; http://dx.doi.org/10.1016/S0960-9822(03)00204-5
28. Yi C, Shen Z, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L, et al. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Sci Signal 2013; 6:ra77; PMID:24003254; http://dx.doi.org/10.1126/scisignal.2004060
29. Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci U S A 2011; 108:11930-5; PMID:21730131; http://dx.doi.org/10.1073/pnas.1103345108
30. Stephenson RO, Yamanaka Y, Rossant J. Disorganized epithelial polarity and excess trophectoderm cell fate in preimplantation embryos lacking E-cadherin. Development 2010; 137:3383-91; PMID:20826529; http://dx.doi.org/10.1242/dev.050195
31. Gladden AB, Hebert AM, Schneeberger EE, McClatchey AI. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell 2010; 19:727-39; PMID:21074722; http://dx.doi.org/10.1016/j.devcel.2010.10.008
32. Cockburn K, Biechele S, Garner J, Rossant J. The Hippo pathway member Nf2 is required for inner cell mass specification. Curr Biol 2013; 23:1195-201; PMID:23791728; http://dx.doi.org/10.1016/j.cub.2013.05.044
33. Adler JJ, Johnson DE, Heller BL, Bringman LR, Ranahan WP, Conwell MD, Sun Y, Hudmon A, Wells CD. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc Natl Acad Sci U S A 2013; 110:17368-73; PMID:24101513; http://dx.doi.org/10.1073/pnas.1308236110
34. Chan SW, Lim CJ, Guo F, Tan I, Leung T, Hong W. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation. J Biol Chem 2013; 288:37296-307; PMID:24225952; http://dx.doi.org/10.1074/jbc.M113.527598
35. Dai X, She P, Chi F, Feng Y, Liu H, Jin D, Zhao Y, Guo X, Jiang D, Guan KL, et al. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis. J Biol Chem 2013; 288:34041-51; PMID:24106267; http://dx.doi.org/10.1074/jbc.M113.518019
36. Alarcon VB. Cell polarity regulator PARD6B is essential for trophectoderm formation in the preimplantation mouse embryo. Biol Reprod 2010; 83:347-58; PMID:20505164; http://dx.doi.org/10.1095/biolreprod.110.084400
37. Dard N, Le T, Maro B, Louvet-Vallée S. Inactivation of aPKClambda reveals a context dependent allocation of cell lineages in preimplantation mouse embryos. PLoS One 2009; 4:e7117; PMID:19768116; http://dx.doi.org/10.1371/journal.pone.0007117
38. Plusa B, Frankenberg S, Chalmers A, Hadjantonakis AK, Moore CA, Papalopulu N, Papaioannou VE, Glover DM, Zernicka-Goetz M. Downregulation of Par3 and aPKC function directs cells towards the ICM in the preimplantation mouse embryo. J Cell Sci 2005; 118:505-15; PMID:15657073; http://dx.doi.org/10.1242/jcs.01666
39. Hergovich A, Schmitz D, Hemmings BA. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Biophys Res Commun 2006; 345:50-8; PMID:16674920; http://dx.doi.org/10.1016/j.bbrc.2006.03.244
40. Yin F, Yu J, Zheng Y, Chen Q, Zhang N, Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 2013; 154:1342-55; PMID:24012335; http://dx.doi.org/10.1016/j.cell.2013.08.025
41. Sansores-Garcia L, Bossuyt W, Wada K, Yonemura S, Tao C, Sasaki H, Halder G. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J 2011; 30:2325-35; PMID:21556047; http://dx.doi.org/10.1038/emboj.2011.157
42. Wada K, Itoga K, Okano T, Yonemura S, Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development 2011; 138:3907-14; PMID:21831922; http://dx.doi.org/10.1242/dev.070987
43. Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 2012; 26:54-68; PMID:22215811; http://dx.doi.org/10.1101/gad.173435.111
44. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012; 150:780-91; PMID:22863277; http://dx.doi.org/10.1016/j.cell.2012.06.037
45. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 2010; 20:573-81; PMID:20362447; http://dx.doi.org/10.1016/j.cub.2010.01.055
46. Chen CL, Gajewski KM, Hamaratoglu F, Bossuyt W, Sansores-Garcia L, Tao C, Halder G. The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci U S A 2010; 107:15810-5; PMID:20798049; http://dx.doi.org/10.1073/pnas.1004060107
47. Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, Hartleben B, Engel C, Moeller MJ, Englert C, Bollig F, et al. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci U S A 2009; 106:8579-84; PMID:19439659; http://dx.doi.org/10.1073/pnas.0811691106
48. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG, Rossant J, Wrana JL. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-ß-SMAD pathway. Dev Cell 2010; 19:831-44; PMID:21145499; http://dx.doi.org/10.1016/j.devcel.2010.11.012
49. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti AR, Poletti A, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 2011; 147:759-72; PMID:22078877; http://dx.doi.org/10.1016/j.cell.2011.09.048
50. Adler JJ, Heller BL, Bringman LR, Ranahan WP, Cocklin RR, Goebl MG, Oh M, Lim HS, Ingham RJ, Wells CD. Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth. J Biol Chem 2013; 288:15181-93; PMID:23564455; http://dx.doi.org/10.1074/jbc.M112.446534